The role of antithrombin in patients with toxic epidermal necrolysis

LIPOVÝ, Břetislav and Michaela CVANOVÁ. The role of antithrombin in patients with toxic epidermal necrolysis. Burns. OXFORD: ELSEVIER SCI LTD, 2017, vol. 43, No 5, p. 1135-1137. ISSN 0305-4179. Available from: https://dx.doi.org/10.1016/j.burns.2017.01.031.

Basic information

Original name

The role of antithrombin in patients with toxic epidermal necrolysis

Authors

LIPOVÝ, Břetislav (203 Czech Republic, guarantor, belonging to the institution) and Michaela CVANOVÁ (203 Czech Republic, belonging to the institution)

Edition

Burns, OXFORD, ELSEVIER SCI LTD, 2017, 0305-4179

---

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30218 General and internal medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.134

RIV identification code

RIV/00216224:14110/17:00098654

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.burns.2017.01.031

UT WoS

000403985900032

Keywords in English

antithrombin

Tags

EL OK

Tags

International impact, Reviewed

---

Abstract

V originále

Toxic epidermal necrolysis (TEN) is a rare systemic disease, which is predominantly manifested in the skin and mucous membranes. Its indicated incidence in the population is 0.5–1.5 cases per million inhabitants a year. It is the most severe syndrome from the SCARs group (Severe Cutaneous Adverse Reactions) with mortality around 30–50%.